Background: Percutaneous mitral valve repair (PMVR) using the MitraClip™ system has become a valuable alternative in patients with severe mitral regurgitation (MR) and high surgical risk. We sought to evaluate the prognostic value of the SYNTAX II score (SSII) in patients with concomitant coronary artery disease (CAD) undergoing a Mitraclip procedure.
Methods: In seventy-five consecutive patients who underwent PMVR at the University Heart Center Zürich and the Cardiocentro Ticino, the SSSII was calculated at baseline. Clinical endpoints comprised of all-cause mortality, mitral valve surgery due to failure of PMVR or reoperation, hospitalization for congestive heart failure, heart transplantation and the composite of all four endpoints.
Results: Patients were followed for a median of 271days. And were divided in tertiles of SSII: SSII low ≤46.5 (n=25), SSII mid 46.6-54.4 (n=25) and SSII high ≥54.5 (n=25). Patients in the highest SSII tertile had a lower left ventricular ejection fraction (33% vs. 40% vs. 53%) with a higher log-BNP (3.6 vs. 3.45 vs. 3.16) when compared to SSII mid and SSII low, respectively. However, the anatomical syntax score (SS) did not differ significantly within the tertiles (9.1±6.3 (SSII Low) vs 9.5±7.6 (SSII Mid) vs 10.2±6.7(SSII High), p=0.837). The primary endpoint occurred in 33% of patients (n=25). By multivariate analysis patients in the high SSII tertile (OR=6.12, 95% confidence interval, [CI] 1.45-25.86, p=0.014) and patients with a history of MI (OR=3.57, 95% confidence interval, [CI] 1.17-10.88, p=0.025) were at significantly higher risk of experiencing adverse events. Furthermore, in a combined outcome ROC curve analysis, the SSII showed good discrimination with an AUC of 0.73, p=0.001. A cutoff SSII >49 has been identified to have a sensitivity of 83% and specificity of 53% with approximately 45% of the patients experiencing an event during follow-up.
Conclusion: Using SSII in CAD patients undergoing PMVR is feasible and of prognostic significance hence widening its clinical utility in valvular heart disease.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijcard.2017.02.049 | DOI Listing |
Qual Manag Health Care
October 2024
Author Affiliations: Combined Neurosurgical and Orthopedic Spine Program, Department of Orthopedic Surgery, University of British Columbia, Vancouver, British Columbia, Canada. (Drs Moskven, Craig, Banaszek, Inglis, Ailon, Charest-Morin, Dea, Dvorak, Fisher, Kwon, Paquette, and Street, and Mrs Belanger,); Arthritis Research Canada, Richmond, British Columbia, Canada. (Dr Sayre), and Division of Critical Care Medicine, University of British Columbia, Vancouver, British Columbia, Canada. (Drs Chittock, and Griesdale).
Clin Res Cardiol
October 2024
Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Background: A routine echocardiogram aims at identifying only regional wall motion abnormality (RWMA) or left ventricle diastolic dysfunction (LVDD) for coronary artery disease (CAD). When absent, a study is often labeled "normal." This creates an unmet need to identify and add subtle markers of CAD to the routine echocardiogram to increase the diagnostic yield.
View Article and Find Full Text PDFJ Clin Med
October 2024
Department of Physiology, Medical Specialization Training Center (TUSMER), Ankara 06230, Turkey.
Rev Cardiovasc Med
September 2024
Department of Cardiology, Huadong Hospital Affiliated to Fudan University, 200040 Shanghai, China.
J Foot Ankle Res
September 2024
University of Sydney School of Health Sciences & Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!